Review

membrane proteome array (mpa) (Integral Molecular Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Integral Molecular Inc membrane proteome array (mpa)
Membrane Proteome Array (Mpa), supplied by Integral Molecular Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+membranes/membrane+proteome+array++mpa++platform/pm40275251-75-0-8
Average 90 stars, based on 1 article reviews

membrane proteome array (mpa) - by Bioz Stars, 2026-10

90/100 stars

Images

other:

Article Title: A preclinical study of allogeneic CD19 chimeric antigen receptor double-negative T cells as an off-the-shelf immunotherapy drug against B-cell malignancies.
Article Snippet: Membrane proteome array (MPA) screening was conducted by Integral Molecular, Inc. (Shanghai, China).

Article Title: Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer
Article Snippet: Integral Molecular, Inc. (Philadelphia, PA) performed specificity testing of IgG1 F12 using the Membrane Proteome Array (MPA) platform, in which 6,000 distinct human membrane proteins (representing over 94% of the human membrane proteome, including single-pass, multi-pass, and GPI-anchored proteins, including GPCRs, ion channels, and transporters) are individually overexpressed in live cells by plasmids transfection in separate wells of a 384-well plate.

Article Title: Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors
Article Snippet: The Membrane Proteome Array (MPA) screening was conducted at Integral Molecular, Inc. (Philadelphia, PA, USA).

Article Title: A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies
Article Snippet: Membrane proteome array (MPA) screening was conducted by Integral Molecular, Inc. (Shanghai, China).

Article Title: Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer.
Article Snippet: Membrane proteome array assay Integral Molecular, Inc. (Philadelphia, PA) performed specificity testing of IgG1 F12 using the Membrane Proteome Array (MPA) platform,25 in which 6,000 distinct human membrane proteins (representing over 94% of the human membrane proteome, including single-pass, multi-pass, and GPIanchored proteins, including GPCRs, ion channels, and transporters) are individually overexpressed in live cells by plasmids transfection in separate wells of a 384-well plate.

Article Title: MUC18-Directed chimeric antigen receptor T cells for the treatment of mucosal melanoma.
Article Snippet: Membrane proteome array (MPA) screening were conducted at Integral Molecular, Inc (PA, USA).

Article Title: Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET Agents
Article Snippet: 3 Membrane Proteome Array (MPA) was performed by Integral Molecular, Inc. (Philadelphia, PA, USA) to specificity test VH-Fc 2A10 using the MPA platform, using the previously described sample preparation protocol16.

Membrane:

Article Title: A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
Article Snippet: .. The membrane proteome array screen was conducted by Integral Molecular, Inc. (USA). ..

Review

membrane proteome array (mpa) (Integral Molecular Inc)

Structured Review

Images

Related Articles

other:

Membrane:

Similar Products

Image Search Results